Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXRL5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,903
Award facts
- Contract value 100% obligated
- $32,903.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,903.21 delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used in weight management and metabolic disease treatment, reflecting the Department of Defense's pharmaceutical supply requirements for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting portfolio primarily with the Defense Logistics Agency and its Medical Supply Chain, demonstrating established capability in fulfilling federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FXRL5?
SPE2DR26FXRL5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FXRL5 worth?
The government has obligated $32,903 on SPE2DR26FXRL5.
Is contract SPE2DR26FXRL5 an order under another contract?
Yes. SPE2DR26FXRL5 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXRL5 competed?
The extent of competition for SPE2DR26FXRL5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award